Question 1

What specific benefits do you think I might gain from using the Optune device?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma clinical trial (NCT01892397). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the Optune treatment compare to other options I have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma clinical trial (NCT01892397). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects or risks associated with using Optune?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma clinical trial (NCT01892397). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic for monitoring during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma clinical trial (NCT01892397). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my condition worsens while I am in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma clinical trial (NCT01892397). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my insurance cover the costs associated with this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma clinical trial (NCT01892397). Contact the study team or your healthcare provider for specific answers.

What this study is about